Tag Archives: Viekira Pak

A new report by IMS Institute for Healthcare Information announces U.S drug spending during 2014 at a record $374 billion. The record spend represented a 13% increase over 2013.  This should come as no surprise to prescription drug plan sponsors trying to control and reduce prescription drug costs.  They’ve watched as the predictions regarding specialty […]

A PBM’s formulary holds the “keys to the kingdom” when it comes to reducing prescription drug costs for a plan sponsor. A formulary is a list of drugs that is developed and maintained by a PBM for use by their clients. It determine what drugs are considered preferred (thus requiring a lower member co-payment) and […]